Farmas USA

Todo lo que huela a delay siempre es malo, la cuestion es "cuanto" para una fase 1.

De donde has sacado esa info tb comentan esto:

"Its Primary Outcome Measures is the Number of subjects experiencing dose limiting toxicity (DLT) for Time Frame: Up to Day 28 of Cycle 1. It seems that this part was completed in Sept-2015.

Obviously, PFS and OS will take longer time. It seems that OS might be longer than expected, and they move the study completion date from Aug-2016 to Jul-2017"

El hermetismo de la compañia es tal que o te escuchas las webcast o uno anda muy perdido.

http://investor.thresholdpharm.com/events.cfm

El estudio en cuestion es este:

https://clinicaltrials.gov/ct2/show/NCT02047500?term=Phase+I+TH-302+Plus+Gemcitabine+Plus+Nab-Paclitaxel+in+Pancreatic+Cancer&rank=1

y los cambios efectivamente aqui quedan registrados:

https://clinicaltrials.gov/archive/NCT02047500/2015_11_09/changes

THLD

NVAX

Muy interesante esa página por lo variado y amplio de los datos.

Según MorningStar que es la página que yo sigo habitualmente para seguir el porcentaje de instituciones estamos ya en un 70,56% desde el 69,08% de ayer. Ese simple 1,48% de ascenso suponen casi 3,2 millones de acciones más en manos de las instituciones.
http://investors.morningstar.com/ownership/shareholders-overview.html?t=NVAX®ion=USA&culture=en_US

Toma !

OFF TOPIC

Yoga may lessen side effects in men undergoing prostate cancer treatment

first-of-its-kind study, led by Neha Vapiwala, MD, an associate professor in the department of Radiation Oncology at PSOM and Penn's Abramson Cancer Center, found that general quality of life and measurements of side effects often experienced by prostate cancer patients—including fatigue, sexual health, and urinary incontinence—were stable throughout a course of outpatient radiation therapy among the men participating in an intensive yoga program.

"Data have consistently shown declines in these important measures among prostate cancer patients undergoing cancer therapy without any structured fitness interventions, so the stable scores seen with our yoga program are really good news," Vapiwala said.

http://medicalxpress.com/news/2015-11-yoga-lessen-side-effects-men.html

P. D: estaba ya, pero acabo de inaugurar mi cuenta de Stocktwits, con el mismo nombre y avatar

Vaya, menuda sorpresa, los hombres se tiraron como locos a por la Viagra pero las mujeres pasan de Addyi. No me lo esperaba...

More than half a million men got prescriptions for Viagra in its first month on the market in 1998. The number of prescriptions for Addyi, the women’s libido-boosting pill, in its first few weeks? 227.

Valeant's Newest Problem: The Female Libido Pill Isn't Selling

http://www.bloomberg.com/news/articles/2015-11-17/valeant-s-newest-problem-the-female-libido-pill-isn-t-selling

VRX - PTN

No puedo evitar decirlo: os lo dije. La líbido de la mujer se cura con cariño, cunilingus e hitachis, no con pastillas.

Algunas se curan con joyas y billetes...jiji

Eso no es líbido, es resignación o trabajo. :p